Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01470209
Title A Phase I Study of BKM120 and Everolimus in Advanced Solid Malignancies
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Emory University
Indications

lung cancer

Advanced Solid Tumor

Therapies

Buparlisib + Everolimus

Age Groups: adult senior

Additional content available in CKB BOOST